Your browser doesn't support javascript.
loading
Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial.
Iseri, Ken; Watanabe, Makoto; Yoshikawa, Hisako; Mitsui, Hisao; Endo, Teruhiko; Yamamoto, Yuichiro; Iyoda, Masayuki; Ryu, Kakei; Inaba, Taro; Shibata, Takanori.
Affiliation
  • Iseri K; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Watanabe M; Nephrology Center, Makita General Hospital, Tokyo, Japan.
  • Yoshikawa H; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Mitsui H; Nephrology Center, Makita General Hospital, Tokyo, Japan.
  • Endo T; Nephrology Center, Makita General Hospital, Tokyo, Japan.
  • Yamamoto Y; Hanedaoozora Dialysis Clinic, Tokyo, Japan.
  • Iyoda M; Adachimotoki Jin Dialysis Clinic, Tokyo, Japan.
  • Ryu K; Adachimotoki Jin Dialysis Clinic, Tokyo, Japan.
  • Inaba T; Hanedaoozora Dialysis Clinic, Tokyo, Japan.
  • Shibata T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
J Bone Miner Res ; 34(6): 1014-1024, 2019 06.
Article in En | MEDLINE | ID: mdl-30690785

Full text: 1 Database: MEDLINE Main subject: Blood Vessels / Bone and Bones / Renal Dialysis / Alendronate / Denosumab Type of study: Clinical_trials Language: En Journal: J Bone Miner Res Year: 2019 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Blood Vessels / Bone and Bones / Renal Dialysis / Alendronate / Denosumab Type of study: Clinical_trials Language: En Journal: J Bone Miner Res Year: 2019 Type: Article Affiliation country: Japan